Dossier assessment

Vildagliptin - Benefit assessment according to §35a Social Code Book V (dossier assessment)

Status
Status: Commission completed
Project no.
A14-46
Last updated

Report documents

  1. Extract of dossier assessment

    Vildagliptin - Benefit assessment according to §35a Social Code Book V (dossier assessment)

    published on
    Document type
    PDF-Dokument, 158 kB, EN, PDF
  2. Dossier assessment

    Vildagliptin - Benefit assessment according to §35a Social Code Book V (dossier assessment)

    published on
    Document type
    PDF-Dokument, 339 kB, DE, PDF

Press releases

Vildagliptin for type 2 diabetes: no suitable data for combination with sulfonylurea

New study not only compared drugs / effects might have been caused by different therapeutic strategies alone

Project details

Project no.
A14-46
Commission
Commission awarded on 03.12.2014 by the Federal Joint Committee (GBA).
Report type
Dossier assessment
Status
Commission completed
Department/Division
Drug Assessment
Topic
Digestion, metabolism and hormones
Note

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.

Connected Projects

  1. Dossier assessment

    Vildagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

    Project no.
    A13-16
    Last updated

    Status: Commission completed

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form